Asthma associated factors as targets for treating atopic allergies including asthma and related disorders

Details for Australian Patent Application No. 2003200686 (hide)

Owner Genaera Corporation

Inventors Nicolaides, Nicholas C.; Maloy, W Lee; Kari, U. Prasad; Levitt, Roy Clifford

Agent FB Rice

Pub. Number AU-B-2003200686

Parent 56549

Filing date 25 February 2003

Wipo publication date 1 May 2003

Acceptance publication date 1 March 2007

International Classifications

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

13 March 2003 Complete Application Filed

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2003200686

22 May 2003 Section 223 Application Allowed

  Genaera Corporation The time in which to make a further application for a divisional patent has been extended to 26.02.2003 . Address for service in Australia - FB Rice & Co 605 Darling BalStreet main NSW 2041

26 June 2003 Amendment Made

  The nature of the amendment is: Amend the name of the co-inventor to read Nicolaides, Nicholas C. and Kari, U. Prasad and Maloy, W Lee

17 March 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

26 May 2005 Section 223 Application Received

  Genaera Corporation An application to extend the time from 23 Aug 2004 to 23 Apr 2005 in which to pay a continuation fee has been filed . Address for service in Australia - FB Rice & Co Level 23 44 Market Street SYDNEY NSW 2000

21 July 2005 Section 223 Application Allowed

  Genaera Corporation The time in which to pay a continuation fee has been extended to 23 Apr 2005. Address for service in Australia - FB Rice & Co Level 23 44 Market Street SYDNEY NSW 2000

1 March 2007 Application Accepted

  Published as AU-B-2003200686

28 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003200687-Medicament excipient particles for tissue-specific application of a medicament

2003200685-Systems and methods for remotely controlling medication infusion and analyte monitoring